These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38197387)

  • 21. Impact of diastolic pulmonary gradient and pulmonary artery pulse index on outcomes in heart transplant patients-Results from the Eurotransplant database.
    Wagner T; Magnussen C; Bernhardt A; Smits JM; Steinbach K; Reichenspurner H; Kirchhof P; Grahn H
    Front Cardiovasc Med; 2022; 9():1036547. PubMed ID: 36588552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study.
    Karia N; Howard L; Johnson M; Kiely DG; Lordan J; McCabe C; Pepke-Zaba J; Ong R; Preiss M; Knight D; Muthurangu V; Coghlan JG
    Eur Heart J; 2023 Nov; 44(44):4678-4691. PubMed ID: 37619574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease.
    Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y
    J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.
    Maeder MT; Weber L; Pohle S; Chronis J; Baty F; Rigger J; Brutsche M; Haager P; Rickli H; Brenner R
    Eur Heart J Open; 2024 May; 4(3):oeae037. PubMed ID: 38812478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
    J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
    Naeije R; D'Alto M
    Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
    Maeder MT; Weber L; Weilenmann D; Chronis J; Joerg L; Pohle S; Haager PK; Brutsche M; Neumann T; Schoch OD; Rickli H
    Clin Cardiol; 2021 Sep; 44(9):1276-1285. PubMed ID: 34219245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Brunner NW; Yue SF; Stub D; Ye J; Cheung A; Leipsic J; Lauck S; Dvir D; Perlman G; Htun N; Fahmy P; Prakash R; Eng L; Ong K; Tsang M; Cairns JA; Webb JG; Wood DA
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1185-1191. PubMed ID: 28471090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
    Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
    Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.
    Tampakakis E; Leary PJ; Selby VN; De Marco T; Cappola TP; Felker GM; Russell SD; Kasper EK; Tedford RJ
    JACC Heart Fail; 2015 Jan; 3(1):9-16. PubMed ID: 25453535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamics of the diastolic pressure gradients in acute heart failure: implications for the diagnosis of pre-capillary pulmonary hypertension in left heart disease.
    Aronson D; Hardak E; Burger AJ
    Pulm Circ; 2019; 9(1):2045894018815438. PubMed ID: 30419797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
    Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
    J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.
    Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N
    Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    Dahiya G; Kyvernitakis A; Elhamdani A; Begg A; Doyle M; Elsayed M; Bailey S; Raina A; Kanwar M; Biederman RWW; Benza RL
    J Heart Lung Transplant; 2023 Feb; 42(2):275-282. PubMed ID: 36437170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation.
    Laimoud M; Hakami E; Maghirang MJ; Mohamed T
    Egypt Heart J; 2023 Dec; 75(1):102. PubMed ID: 38117355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
    Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M
    Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure.
    Tsuchida K; Yamada H; Yamasaki Y; Suzuki K; Kongoji K; Akashi Y; Ozaki S
    Mod Rheumatol; 2015 Sep; 25(5):744-7. PubMed ID: 25736353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.